Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Eurioste
    Junior Member
    • Jun 2017
    • 5

    #1

    Using ChIP-seq NarrowPeaks peak calls as machine-learning predictors

    I wish to train a classificatory computational model for the predicting the occurrence (or not) of certain genomic features using NarrowPeaks peak calls (BED files) obtained for several epigenetic modifications (mostly histone modifications obtained from the Roadmap Epigenomics Project) as predictors.

    The genomic features have variable length (usually around 200bp). The NarrowPeaks also have variable length and abundance.

    I would like to ask your suggestions about the best way of using the peak calls data as prediction for the model.

    For instance, for a given epigenetic modification I may:

    1-Use the simple fact that the genomic feature intersects any peak of epigenetic mark as a Yes/No categorical value

    2-Use the signalValue, pValue or qValue of the intersected peak as a numeric variable.

    3-Use some sort of relative overlap between the features

    Should I worry about calculating some kind of enrichment score for the cases were the peaks are smaller than the features and may overlap many? If so, how is the best way (in your opinion) to proceed?

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
70 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...